 family in a better financial position by not going. Which is partly why cancer trial participation is so low. In fact, recent research in the journal Cancer estimates that only two to eight percent of cancer patients enroll. A 2019 study in the Journal of Clinical Oncology reveals that nearly half of cancer trials aren't able to find enough participants to complete the research. This leads to small sample sizes that can't provide valid results.